Comparison of candesartan and felodipine alone and combined in the treatment of hypertension: A single-center, double-blind, randomized, crossover trial
Articles > Article · 2003
Authors: S Nalbantgil, Mehdi ZOGHİ, Filiz ÖZERKAN ÇAKAN, Bahar BOYDAK, I Nalbantgil, R Onder, M Akin
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, Journal Indexed in SCI Expanded, International, 2003, vol 64, pp 380-388
DOI: 10.1016/s0011-393x(03)00128-0
Summary
Background. In the past decade, many studies have indicated that the combination of low doses of different classes of antihypertensive agents may be more efficacious than monotherapy while minimizing the likelihood of dose-dependent adverse effects (AEs).